BCS Course Materials

Description | Syllabus | Sample Exams | Archives |
BCS 246/546: Biological Basis of Mental Disorders

Monday, Wednesday, 4:50-6:05

Spring 2003
Professor Carol Kellogg Professor Peter Como
Office: Meliora 186 Office: Meliora 171
Telephone: 5-4801 Telephone: 5-8726
Office Hours: 4:00-4:30, M &W or by appointment Office Hours: 4:15-4:45, M & W or by appointment
e-mail: kellogg@bcs.rochester.edu e-mail: pcomo@mct.rochester.edu

Course Intent: The objective of this course is to present current understanding of biologic mechanisms involved in the etiology and pathology of various brain disorders, including those disorders generally classified as "mental disorders." Basic concepts of neurobiology will be presented coincidentally with discussion of the clinical presentation and management of the various disorders.

Texts: Andreasen, Nancy C. Brave New Brain: Conquering Mental Illness in the Era of the Geneome, Oxford University Press, 2001. This book provides clear descriptions of various mental illnesses and also places these illnesses in the context of biologic disorders. REQUIRED

Pliszka, S.R. Neuroscience for the Mental Health Clinician, The Guilford Press. 2003. This book provides more details on basic mechanisms of neurotransmission. REQUIRED

Charney, Dennis S., Nestler, Eric J., Bunney, Benjamin S., Neurobiology of Mental Illness, Oxford University Press, 1999. We are using the softcover edition of this text. This is an edited text providing current information on the understanding of neurobiologic mechanisms contributing to mental disorders. It is quite detailed. Specific chapters from this book will be required reading for all students, and those chapters will be put on electronic reserve. For students registered for BCS 546, this book is required.

Additional readings that are assigned will be placed on electronic reserve. Readings on electronic reserve are marked by an * in the class schedule.

Course Evaluation: Five exams accounting for 100% of the final grade will be given. Both take-home and in-class exams are scheduled. The in-class exams may include discussion questions for which study questions will be handed out prior to the in-class exams. The following ranges provide a general guideline for estimating final grades:

> 90%=A-/A 78%-89%= B-/B/B+ 65%-77%= C-/C/C+
Lecture Schedule and Assigned Readings
Required readings in bold type
Readings marked with * are on Electronic Reserve
Hormone: Brain interactions and Stress-Responsive Neural Mechanisms
* McEwen, B. (1999) Endocrine effects on the brain and their relationship to behavior. In: Siegel, G.J. et al., Basic Neurochemistry, Lippincott Williams & Wilkins, pp.1007-1026.

* Bear, M.F., Connors, B.W., Paradiso, M.A. Chemical control of the brain and behavior, In: Neuroscience: Exploring the Brain, second edition, Ch. 15, Lippincott, Williams & Wilking, pp. 496-512. P. Como
Jan. 15 Introduction
Defining Mental Illness:
Andreasen, Ch. 1-3 & 7
P. Como
UNIT 1: Basic Concepts of Neurotransmitter Function
Jan. 20 No Class: Martin Luther King Day
Jan. 22 Chemical Messenger Systems:
Pliszka, Ch. 4, Andreasen, pp. 75-86 and review pp. 41-75; Charney, Ch.2
C. Kellogg
Jan. 27 Transmitter Role in Regulating Neural Activity:
Pliszka, Ch.3 pp. 32-50. Charney, Ch.3, 4
C. Kellogg
Jan. 29 Mechanisms of Neural Plasticity:
Charney, Ch.* 5, *6; Andreasen, Ch. 5
C. Kellogg
Feb. 3 C. Kellogg
Take-Home Problem Set: Due in Feb. 10
Unit 2: Neurobiology of Psychoses
Feb. 5 The major psychoses:
Andreasen, Ch. 8, pp. 186-197; Pliszka, Ch.12, pp. 225-239
Charney, Ch. 15
P. Como
Feb. 10 Neurobiology of Psychoses:
Pliszka, Ch. 12 pp. 225-239; Ch. 8, pp. 136-141; Andreasen, pp. 197-210; Charney, *Ch. 18, 19, 20
C. Kellogg
Feb. 12 Clinical management of psychoses:
Andreasen, pp. 210-214; Charney, *Ch. 22
P. Como
UNIT 3: Mood Disorders
Feb. 17 Classification of Mood Disorders:
Andreason, Ch.9, pp. 215-234; Pliszka, Ch. 11, pp. 200-216
Charney, Ch. 23
Feb. 19 Neurobiology of Mood Disorders:
Andreason, Ch. 9, pp. 234-246; Pliszka, Ch. 11, pp. 200-216; Charney, *Ch. 26; Charney, Ch. 27
C. Kellogg
Feb. 24 Clinical management of Mood Disorders:
Andreason, Ch. 9; pp. 246-252; Charney, *Ch. 31
P. Como
Take-Home Exam over UNITS 2 and 3: Due in March 3
UNIT 4: Anxiety Disorders
Feb. 26 Classification of anxiety disorders:
Andreasen, Ch. 11; Pliszka, Ch.11, pp. 216-220; Charney, Ch. 32
P. Como
March 3 Neurobiology of Anxiety Disorders
Charney, Ch. *34, *36; Charney, Ch. 35; Pliszka, Ch. 5, Ch.11, pp. 216-220
C. Kellogg
March 5 Description and Neurobiology of Obsessive-Compulsive Disorder; Charney, *Ch. 37 P. Como
March 10, 12 Spring Break
March 17 Clinical Management of Anxiety Disorders
Andreasen, pp. 311-314; Charney, *Ch. 39
P. Como
Unit 5: Substance Abuse
March 19 Neural Basis of addiction:
Charney, Chs. *41, *43; Pliszka, Ch.10, pp. 185-192
C. Kellogg
March 24 The Hijacked Brain: Video C. Kellogg
March 26 In-Class Exam over UNITS 4 and 5
Unit 6: Neurodegenerative Disorders
March 31 Neural Mechanisms of Cell Death
*Leist, M. and Nicotera, P. (1998) Apoptosis, excitotoxicity, and neuropathology. Exp. Cell Res. 239:183-201.
C. Kellogg
April 2 Clinical Description of Basal Ganglia Disorders
*Chapter 10, ParkinsonŐs Disease. In: P.G. Strange, Brain Biochemistry and Brain Disorders, Oxford Press (1994), pp. 161-186.

*Biglan, K.M., Shoulson, I. Chapter 14, HuntingtonŐs disease. In: J.Jankovic, Ed., ParkinsonŐs disease and movement disorders, In Press.
P. Como
April 7 Neuropathology of Basal Ganglia and Cortical Degenerative Disorders
*Cattaneo, E., Rigamonti, D., Goffredo, D., Zuccato, C. Squitieri, F., Sipione, S., (2001) Loss of normal huntingtin function: new developments in HuntingtonŐs disease research, Trends in Neurosci., 24: 182-188.

*Lozano, A., Lang, A., Hutchison, W.D., Dostrovsky, J.O. (1998) New developments in understanding the etiology of ParkinsonŐs disease and in its treatment. Current Opinion in Neurobiol., 8: 783-790

*Felician O, Sandson TA. (1999) The neurobiology and pharmacotherapy of Alzheimer's disease. J Neuropsychiatry Clin Neurosci, 11:19-31.
C. Kellogg
April 9 Clinical Description of Cortical Degenerative Disorders
Andreason, Ch. 10; Charney, *Ch. 46
Dr. Mark Mapstone
April 14 Clinical Management of Degenerative Disorders
*Mayeux R, Sano M. Treatment of Alzheimer's disease. (1999), New England Journal of Medicine; 341:1670-1679.

*Felician O, Sandson TA. The neurobiology and pharmacotherapy of Alzheimer's disease. J Neuropsychiatry Clin Neurosci, 1999; 11:19-31.
P. Como
April 16 Issues of Genetic Risk
*Hayden MR. Predictive testing for Huntington's disease: the calm after the storm. Lancet, 2000; 356:1944-1945.

*Hall MA, Rich SS. Laws restricting health insurer's use of genetic information: impact on genetic discrimination. Am J Hum Genet., 2000; 66:293-307.
P. Como
April 21 In Class Exam over Unit 6
Unit 7: Sex-Related Disorders
April 23 Sex-related Neurobiology
*Breedlove, S.M., Cooke, B.M., Jordan, C.L. (1999) The orthodox view of brain sexual differentiation. Brain Behav Evol, 54: 8-14.

*Pilgrim, C. & Hutchison, J.B. (1994) Developmental regulation of sex differences in the brain: Can the role of gonadal steroids be redefined. Neuroscience, 60: 843-855.
C. Kellogg
April 28 Eating Disorders
*Kaye, W.H., Klump, K.L., Frank, G.K.W., Strober, M. (2000) Anorexia and Bulimia Nervosa, Ann. Re. Med., 551:299-313; Charney, Ch. 68
April 30 Attention Deficit Disorders:
Pliszka, Ch. 9; Charney, Ch. 60
TAKE-HOME FINAL HANDED OUT
P. Como
May 9 TAKE-HOME FINAL EXAM DUE BY 4:00 pm

Last modified: 2/18/2003
questions and comments
about this site